Inclisiran
Records for this ingredient, by country (identity only).
ATC C10AX16 · 11 markets · 16 records
AU 3 records · 2 shown of 2
- 284 mg/1.5 mLinjectionLEQVIO
- 284 mg per mL / per unit basis not statedinjectionLEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 3 records · 0 shown of 0
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 shown of 1
- 284 mg/1.5 mLinjectionLEQVIO
GB 1 records · 1 shown of 1
- 284 mg/1.5 mLinjectionLeqvio 284mg/1.5ml solution for injection pre-filled syringes
CA 1 records · 1 shown of 1
- 189.333333 mg/1 mLliquidLEQVIO
SG 1 records · 1 shown of 1
- 284 mg per mL / per unit basis not statedinjectionLEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML
ES 1 records · 1 shown of 1
- 284 mg per mL / per unit basis not statedinjectionLEQVIO PRECARGADA
MX 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 1 records · 0 shown of 0
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
JP 1 records · 1 shown of 1
- 300 mg/1.5 mLinjectionレクビオ皮下注300mgシリンジ
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | US | GB | CA | AU | SG | ES | MX | TW | HK | JP | EU |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 284 mg/1.5 mL injection | LEQVIO | Leqvio 284mg/1.5ml solution for injection pre-filled syringes | LEQVIO | ||||||||
| 284 mg per mL / per unit basis not stated cannot compare injection | LEQVIO inclisiran 284 mg /1.5 mL solution for injection in pre-filled syringe | LEQVIO SOLUTION FOR INJECTION IN PREFILLED SYRINGE 284 MG/1.5 ML | LEQVIO PRECARGADA | ||||||||
| 189.333333 mg/1 mL liquid | LEQVIO | ||||||||||
| 300 mg/1.5 mL injection | レクビオ皮下注300mgシリンジ | ||||||||||
unknown | LEQVIO | Leqvio solution for injection in pre-filled syringe LEQVIO SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE WITH NEEDLE GUARD 284MG/1.5ML | LEQVIO | ||||||||
injection | Leqvio solution for injection in pre-filled syringe 樂脂益注射劑 | ||||||||||
liquid | SYBRAVA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in CA · MX · TW · JP and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en CA · MX · TW · JP que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 CA · MX · TW · JP 有记录（未在本表显示）。 另有 4 個規格/劑型僅在 CA · MX · TW · JP 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.